Abbott Expands Commitment To Vascular Device Biz Through Biocompatibles

Abbott's acquisition of Biocompatibles' stent business, unveiled March 18, reflects an expanded commitment by Abbott to its vascular medicine franchise - particularly focusing on high growth market segments like stents, vessel closure and embolic protection